Loading...
Publications 2018-07-03T07:50:54+00:00

Multiple Sclerosis

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy” Journal of Neuroinflammation (2018) 15:64 DOI 10.1186/s12974-018-1103-y Authors: Carmen Navarrete, Francisco Carrillo-Salinas, Belén Palomares, Miriam Mecha, Carla Jiménez-Jiménez, Leyre Mestre, Ana Feliú, Maria L. Bellido, Bernd L. Fiebich, Giovanni Appendino, Marco A. Calzado, Carmen Guaza and Eduardo Muñoz

Scleroderma

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways” Nature Scientific Report (2016) 6:21703 DOI: 10.1038/srep21703 Authors: Carmen del Río, Carmen Navarrete, Juan A.  Collado2, M. Luz  Bellido, María Gómez-Cañas, M. Ruth Pazos, Javier Fernández-Ruiz, Federica Pollastro, Giovanni Appendino, Marco A. Calzado, Irene Cantarero and Eduardo Muñoz

Parkinson’s Disease

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor” Journal of Neuroinflammation (2018) 15:19 DOI 10.1186/s12974-018-1060-5 Authors: Concepción García, María Gómez-Cañas, Sonia Burgaz, Belén Palomares, Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Sara Campo, Joel Ferrer-Hernández, Carolina Pavicic, Carmen Navarrete, M. Luz Bellido, Moisés García-Arencibia, M. Ruth Pazos, Eduardo Muñoz and Javier Fernández-Ruiz

Huntington’s Disease

 “Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity” British Journal of Pharmacology (2017) 4263;4276 DOI: 10.1111/bph.14019 Authors: Xavier Nadal, Carmen del Río,  Salvatore Casano,  Belén Palomares,  Carlos Ferreiro‐Vera, Carmen Navarrete,  Carolina Sánchez‐Carnerero,  Irene Cantarero,  Maria Luz Bellido,  Stefan Meyer, Gaetano Morello,  Giovanni Appendino and Eduardo Muñoz